Developer docs
API playgroundTry for free, no card

Search company profiles

Kortex Ventures

Full company profile

uuid00086an

Namestring
Kortex Ventures
Legal namestring
KX Ventures
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund that invests exclusively in early-stage healthcare technology companies, deploying capital from seed through Series B across Brazil and Latin America. The fund was established as a joint venture between three of Brazil's largest healthcare incumbents — diagnostic laboratory groups Fleury and Sabin, and health insurer Bradesco Saúde — with a target size of approximately R$200 million (~USD 40 million) and a stated plan to make 15 to 18 investments over a 4-year deployment period.

The fund's core product is growth capital coupled with deep sector-specific value-add: portfolio companies gain access to clinical validation environments, diagnostic laboratory distribution channels, regulatory pathway support, and direct relationships with thousands of physicians, partner hospitals, clinics, and insured patient populations through the founding LPs. Kortex positions itself as an activist investor, providing talent recruitment, go-to-market strategy, fundraising assistance, and long-term ecosystem introductions. The portfolio of 12 disclosed companies spans sleep diagnostics (Biologix), AI-driven imaging and laboratory diagnostics (Neuralmed, Huna), at-home testing and vaccination (SiPhox Health, ISA Lab), occupational health (Welbe), and broader health management platforms.

Economically, Kortex operates as a closed-end managed fund: revenue derives from conventional venture capital mechanisms — management fees on committed/deployed capital and carried interest on successful exits — and the fund does not publicly disclose pricing or fee terms. The firm is qualified as (or in the process of qualifying as) a regulated Brazilian investment manager with CVM and ANBIMA membership, and is led by managing partner Gustavo Cavenaghi with a lean team of 1-10 employees.

Short descriptiontext

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund, backed by Fleury, Sabin, and Bradesco Saúde, that invests from seed to Series B in early-stage healthcare technology companies across Brazil and Latin America, providing portfolio founders with clinical validation, distribution access, and strategic support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, corporate venture capital, healthtech investments, seed to series B funding, healthcare innovation fund
Industry1 code
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Fund Management
TypeManaged Services
Description

Kortex Ventures generates returns through traditional VC mechanisms including management fees and carried interest (carry) on successful portfolio exits. The fund is structured as a closed-end investment vehicle targeting 15-18 investments over a 4-year deployment period, with capital returned to LPs upon portfolio company exits or acquisitions.

kortexventures.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kortex Ventures is a corporate venture capital fund that invests in early-stage healthcare technology companies from seed through Series B. The fund deploys capital and provides strategic support — including talent recruitment, fundraising assistance, and channel development — to healthtech entrepreneurs across Brazil and Latin America. Its portfolio spans diagnostics, AI-driven disease detection, at-home health testing, occupational health, and digital health management platforms.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Kortex Ventures is a corporate venture capital fund focused exclusively on healthcare technology investments. The fund is backed by major Brazilian healthcare groups including Fleury, Sabin, and Bradesco Saúde. The fund targets seed to Series B stage companies and acts as activist investors, providing strategic support, talent recruitment, fundraising assistance, and valuable connections to accelerate innovative healthcare businesses. The fund has presence across multiple countries and connections to thousands of doctors, hospitals, clinics and labs.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest LatAm-focused VC firms with active healthcare investments across Brazil, Argentina, and Mexico. Directly comparable as a regional specialist VC operating in Kortex's core geography and stage range.

TypeDirect peer
Description

Brazilian-born multi-stage VC firm with healthcare and life-sciences exposure and a portfolio spanning Brazil and the US. Comparable as a homegrown LatAm generalist with overlapping early-to-growth deal flow similar to Kortex.

TypeDirect peer
Description

Corporate venture capital arm of Sanofi focused on early-stage digital health and biopharma. Highly analogous as a healthcare-only CVC backed by a deep-pocketed healthcare incumbent that provides portfolio companies with clinical and commercial channels.

TypeDirect peer
Description

Healthcare-focused CVC arm of Roche investing in diagnostics, digital health, and biotech. Directly parallel as a diagnostics-and-healthcare CVC providing clinical validation and channel access to portfolio companies.

TypeDirect peer
Description

CVC arm of Novartis investing in life sciences and digital health across stages. Comparable as a global healthcare CVC deploying the same activist-investor playbook and strategic-LP-backing model that Kortex applies regionally.

TypeDirect peer
Description

US/Brazil cross-border VC investing in early-to-growth tech companies including healthtech in Brazil and the US. Comparable as a Trans-LatAm VC with healthcare exposure operating in Kortex's geographies.

7ALLVP
TypeDirect peer
Description

Mexico-based early-stage VC firm with healthcare and enterprise focus across LatAm. Comparable as a regional sector-aware VC that often co-invests alongside strategic partners similar to Kortex's LP network.

TypeEmerging player
Description

US-based early-stage VC focused on healthcare AI and digital health. Listed as a Kortex portfolio company but also an independent fund — overlaps with Kortex's portfolio thesis in AI-driven diagnostics and acts as a US-LatAm bridge investor.

TypeBroad incumbent
Description

Major US VC with a dedicated Bio/Health fund across digital health, biotech, and care delivery. Comparable as a category-defining healthcare VC but at materially larger AUM and global stage range — illustrates the scale gap Kortex must navigate.

TypeEmerging player
Description

US-based VC with growing healthcare exposure alongside consumer-tech. Adjacent as a sector-specialist VC, though primarily US-focused rather than LatAm-based.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kortex Ventures

Venture Capitalkortexventures.com

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund, backed by Fleury, Sabin, and Bradesco Saúde, that invests from seed to Series B in early-stage healthcare technology companies across Brazil and Latin America, providing portfolio founders with clinical validation, distribution access, and strategic support.

What Kortex Ventures does

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund that invests exclusively in early-stage healthcare technology companies, deploying capital from seed through Series B across Brazil and Latin America. The fund was established as a joint venture between three of Brazil's largest healthcare incumbents — diagnostic laboratory groups Fleury and Sabin, and health insurer Bradesco Saúde — with a target size of approximately R$200 million (~USD 40 million) and a stated plan to make 15 to 18 investments over a 4-year deployment period.

The fund's core product is growth capital coupled with deep sector-specific value-add: portfolio companies gain access to clinical validation environments, diagnostic laboratory distribution channels, regulatory pathway support, and direct relationships with thousands of physicians, partner hospitals, clinics, and insured patient populations through the founding LPs. Kortex positions itself as an activist investor, providing talent recruitment, go-to-market strategy, fundraising assistance, and long-term ecosystem introductions. The portfolio of 12 disclosed companies spans sleep diagnostics (Biologix), AI-driven imaging and laboratory diagnostics (Neuralmed, Huna), at-home testing and vaccination (SiPhox Health, ISA Lab), occupational health (Welbe), and broader health management platforms.

Economically, Kortex operates as a closed-end managed fund: revenue derives from conventional venture capital mechanisms — management fees on committed/deployed capital and carried interest on successful exits — and the fund does not publicly disclose pricing or fee terms. The firm is qualified as (or in the process of qualifying as) a regulated Brazilian investment manager with CVM and ANBIMA membership, and is led by managing partner Gustavo Cavenaghi with a lean team of 1-10 employees.

Kortex Ventures firmographics

Firmographics
Name
Kortex Ventures
Legal name
KX Ventures
Website
https://kortexventures.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Kortex Ventures is a São Paulo-based Corporate Venture Capital fund, backed by Fleury, Sabin, and Bradesco Saúde, that invests from seed to Series B in early-stage healthcare technology companies across Brazil and Latin America, providing portfolio founders with clinical validation, distribution access, and strategic support.
Ownership category
akta.pro rank

Kortex Ventures industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms

Keywords

  • Healthcare venture capital
  • Corporate venture capital
  • Healthtech investments
  • Seed to series B funding
  • Healthcare innovation fund

Where Kortex Ventures is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Kortex Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Fund Management: Kortex Ventures generates returns through traditional VC mechanisms including management fees and carried interest (carry) on successful portfolio exits. The fund is structured as a closed-end investment vehicle targeting 15-18 investments over a 4-year deployment period, with capital returned to LPs upon portfolio company exits or acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Kortex Ventures product offering

Product offering

Core offering

Kortex Ventures is a corporate venture capital fund that invests in early-stage healthcare technology companies from seed through Series B. The fund deploys capital and provides strategic support — including talent recruitment, fundraising assistance, and channel development — to healthtech entrepreneurs across Brazil and Latin America. Its portfolio spans diagnostics, AI-driven disease detection, at-home health testing, occupational health, and digital health management platforms.

Product overview

Kortex Ventures is a corporate venture capital fund focused exclusively on healthcare technology investments. The fund is backed by major Brazilian healthcare groups including Fleury, Sabin, and Bradesco Saúde. The fund targets seed to Series B stage companies and acts as activist investors, providing strategic support, talent recruitment, fundraising assistance, and valuable connections to accelerate innovative healthcare businesses. The fund has presence across multiple countries and connections to thousands of doctors, hospitals, clinics and labs.

Differentiator

Problem solved

Functional benefit

Companies that use Kortex Ventures

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Kortex Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Kortex Ventures partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Kortex Ventures competitors and assessment

Company assessment

Direct peers

  • Kaszek Ventures: One of the largest LatAm-focused VC firms with active healthcare investments across Brazil, Argentina, and Mexico. Directly comparable as a regional specialist VC operating in Kortex's core geography and stage range.
  • Monashees: Brazilian-born multi-stage VC firm with healthcare and life-sciences exposure and a portfolio spanning Brazil and the US. Comparable as a homegrown LatAm generalist with overlapping early-to-growth deal flow similar to Kortex.
  • Sanofi Ventures: Corporate venture capital arm of Sanofi focused on early-stage digital health and biopharma. Highly analogous as a healthcare-only CVC backed by a deep-pocketed healthcare incumbent that provides portfolio companies with clinical and commercial channels.
  • Roche Venture Fund: Healthcare-focused CVC arm of Roche investing in diagnostics, digital health, and biotech. Directly parallel as a diagnostics-and-healthcare CVC providing clinical validation and channel access to portfolio companies.
  • Novartis Venture Fund: CVC arm of Novartis investing in life sciences and digital health across stages. Comparable as a global healthcare CVC deploying the same activist-investor playbook and strategic-LP-backing model that Kortex applies regionally.
  • Valor Capital Group: US/Brazil cross-border VC investing in early-to-growth tech companies including healthtech in Brazil and the US. Comparable as a Trans-LatAm VC with healthcare exposure operating in Kortex's geographies.
  • ALLVP: Mexico-based early-stage VC firm with healthcare and enterprise focus across LatAm. Comparable as a regional sector-aware VC that often co-invests alongside strategic partners similar to Kortex's LP network.

Emerging players

  • Tau Ventures: US-based early-stage VC focused on healthcare AI and digital health. Listed as a Kortex portfolio company but also an independent fund — overlaps with Kortex's portfolio thesis in AI-driven diagnostics and acts as a US-LatAm bridge investor.
  • Goodwater Capital: US-based VC with growing healthcare exposure alongside consumer-tech. Adjacent as a sector-specialist VC, though primarily US-focused rather than LatAm-based.

Broad incumbents

  • Andreessen Horowitz (a16z Bio/Health): Major US VC with a dedicated Bio/Health fund across digital health, biotech, and care delivery. Comparable as a category-defining healthcare VC but at materially larger AUM and global stage range — illustrates the scale gap Kortex must navigate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Kortex Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kortex Ventures leadership team

Management profile

Number of profiles

Profiles1 record

Kortex Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kortex Ventures M&A and investment

M&A and investment

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kortex Ventures

What does Kortex Ventures do?

Kortex Ventures is a corporate venture capital fund that invests in early-stage healthcare technology companies from seed through Series B. The fund deploys capital and provides strategic support — including talent recruitment, fundraising assistance, and channel development — to healthtech entrepreneurs across Brazil and Latin America. Its portfolio spans diagnostics, AI-driven disease detection, at-home health testing, occupational health, and digital health management platforms.

Is Kortex Ventures a public or private company?

Kortex Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Kortex Ventures founded?

Kortex Ventures was founded in 2021. It employs 1 to 10 people.

Where is Kortex Ventures based?

Kortex Ventures is headquartered in São Paulo, Brazil, in the Latin America region.

How does Kortex Ventures make money?

One revenue line is on record: venture Capital Fund Management.

Who are Kortex Ventures's main competitors?

Direct peers on record are Kaszek Ventures, Monashees, Sanofi Ventures, Roche Venture Fund, Novartis Venture Fund, Valor Capital Group and ALLVP. Emerging players are Tau Ventures and Goodwater Capital. Andreessen Horowitz (a16z Bio/Health) is listed as a broad incumbent.

Does Kortex Ventures have an API?

No public API is recorded for Kortex Ventures.

What industry is Kortex Ventures in?

Kortex Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Global VenturingKortex Ventures: three-LP fund lets us give startups an honest propositionKortex Ventures, a corporate venture fund for Fleury, Sabin, and Bradesco Saude, has grown its capital to about $50M from an initial $40M. It plans 15-18 investments in digital and personalized healthcare, with a thesis covering diagnostics, precision medicine, and digital health.LAVCABrazil’s ISA LAB Raises BRL60m Round from FIR Capital, Vox Capital, Kortex, OthersBrazil-based at-home vaccination service ISA LAB raised BRL60m (~USD12m) in a funding round led by OXIO and Newfoundland Capital Management. The investment included participation from Yaya Capital, FIR Capital, Vox Capital, Kortex, Bradesco Saude, Scale-Up Ventures, and follow-on investments from Canary, Norte Ventures, and MatterScale.StartupiKlivo estende Série A com Yaya Capital e Kortex Ventures totalizando R$ 50 milhõesKlivo has extended its Series A funding round by R$ 5 million with investments from Yaya Capital and Kortex Ventures, bringing the total raised to R$ 50 million. The additional capital will be used for growth, expansion of care lines, and potential acquisitions, following an initial R$ 45 million announcement in November. This extension underscores strong investor confidence in the healthtech startup's model for chronic patient care coordination.BloomberglineaKlivo anuncia extensão da Série A com Yaya Capital e Kortex VenturesHealthtech Klivo secured an additional R$ 5 million in its Series A funding round from Yaya Capital and Kortex Ventures, supplementing a previous R$ 45 million investment. The new capital will be used to expand product lines into areas like oncology and mental health while improving existing monitoring solutions for chronic diseases. Klivo currently serves 36 clients, including major insurers and corporate self-management plans, aiming to triple its size by year-end.